气虚血瘀型冠心病心绞痛患者红细胞膜成分与血液粘度相关性研究
|
摘要
目的：以气虚血瘀型冠心病心绞痛患者作为考察对象,从血液流变学和红细胞膜成分的变化来探讨导致气虚血瘀型冠心病心绞痛患者红细胞变形性及流动性降低的机制,进一步寻找血瘀证在红细胞膜上的发生机制,为临床合理诊治气虚血瘀型冠心病提供实验依据,并为其作用机制、作用靶点研究提供技术平台。
方法：以老龄大鼠和青年大鼠为研究对象,取血制红细胞膜,测定血液粘度和红细胞膜成分变化,建立两者相关性的研究方法。将18例气虚血瘀型冠心病心绞痛患者、13例健康老人和10例健康青年人分为冠心病人组、健康老人对照组和青年对照组,测定血浆中的生化指标、全血粘度、血浆粘度、红细胞变形性、红细胞膜上的胆固醇含量、唾液酸含量、巯基含量、SOD活性、MDA含量、Na+-K+-ATP酶活力、膜蛋白组成以及激光共聚焦显微镜观察红细胞膜形态变化,以探讨其致病机制。
结果：(1)与健康人比较,气虚血瘀型冠心病心绞痛患者全血粘度、血浆粘度均高于健康人(P<0.01,P<0.05),红细胞变形能力明显降低(P<0.01);血浆和红细胞膜上胆固醇含量明显升高(P<0.01,P<0.05)；而膜上唾液酸含量、巯基含量显著降低(P<0.01,P<0.01);尽管Na+-K+-ATP酶活性和SOD活性降低,丙二醛含量升高,但无统计学意义；(2)与青年人比较,气虚血瘀型冠心病心绞痛患者红细胞形态和骨架发生变化,F-actin含量降低并呈解聚状态；包括带1蛋白、带3蛋白、带4.1蛋白、带4.2蛋白、带5蛋白、原肌球调节蛋白和带6蛋白百分含量均显著降低,健康老人组带1、带3、带4.1、原肌球调节蛋白百分含量均显著高于气虚血瘀型冠心病人组的蛋白含量。
结论：以老龄大鼠和青年大鼠为研究对象,从红细胞膜组分变化,建立了红细胞膜组分与血液粘度相关性所涉及部分指标的研究方法。气虚血瘀型冠心病心绞痛患者的全血粘度、血浆粘度显著升高,红细胞变形能力明显降低,其机制可能是由于红细胞表面唾液酸含量和巯基含量减少,膜胆固醇含量增多、红细胞膜骨架F-actin解聚,膜蛋白组成发生变化,从而导致抗氧化能力低下,膜流动性降低。
Objectives:The coronary heart disease patients who were qi deficiency to blood stasis were observed in this article. The mechanism of the decreasement of red cell deformability and membrane fluidity of coronary heart disease patients were studied through the change of hemorheology and ingredient of erythrocyte membrane. The mechanism of blood stasis that happened in erythrocyte membrane was further looking for. And the results could be as the reference for diagnosis and treatment of coronary heart disease patients who were qi deficiency to blood stasis. The technology platform was established for studying of mechanism and target spot of action.
Methods:The senile rats and young rats were observed in this article. Erythrocyte membrane was prepared. The change of blood viscosity and ingredient of erythrocyte membrane were determined. The research method for the relativity of them was established. Eighteen coronary heart disease patients who were qi deficiency to blood stasis, thirteen healthy old people and ten healthy young people were divided into coronary patient group and healthy old people control group and healthy young people control group. Many indexes such as biochemical indicator of plasma, whole blood viscosity, plasma viscosity, erythrocyte deformability and the content of cholesterol, sialic acid, hydrosulphonyl, MDA, activity of SOD, Na+-K+-ATP enzyme activity of erythrocyte membrane, constitute of membrane protein, change of form of erythrocyte membrane under laser scanning confocal fluorescence microscope were determined. The mechanism of causing blood stasis was investigated in this article.
Results:(1) The whole blood viscosity and plasma viscosity of coronary patient are significantly higher than that of the healthy people (P<0.01,P<0.05); The red cell deformability index is lower than that of healthy people (P<0.01); The contents of cholesterol in erythrocyte membrane and plasma are significantly higher than that of the healthy people (P<0.01,P<0.05). The contents of sialic acid and hydrosulphonyl in erythrocyte membrane are significantly lower than that of the healthy people (P<0.01,P<0.01). SOD and Na+-K+-ATP enzyme activity of erythrocyte membrane are decreasing and the content of MDA is increasing. But there are not statistically significant. (2) Compare with the young people, there are some changes of red cell morphology and membrane skeleton in coronary heart disease patients who were qi deficiency to blood stasis. The content of F-actin is decreased and F-actin is depolymerization. The percentage composition of band 1 protein, band 3 protein, band 4.1 protein, band 4.2 protein, band 5 protein, band 6 protein and tropomodulin of coronary patients are significantly lower than that of the healthy young people. The percentage composition of band 1 protein, band 3 protein and band 4.2 protein of the healthy old people are significantly higher than that of coronary patients.
Conclusions:The senile rats and young rats were as object of study. The research method for the relativity of blood viscosity and ingredient of erythrocyte membrane was established. The whole blood viscosity and plasma viscosity are increased significantly and the red cell deformability is decreased distinctly. The mechanism of decreasing antioxidant ability and membrane fluidity may has relationship with the following points:increasing the content of sialic acid and hydrosulphonyl, reducing the content of cholesterol in erythrocyte membrane, depolymerization of F-actin and the change of composition of membrane protein.
方法：以老龄大鼠和青年大鼠为研究对象,取血制红细胞膜,测定血液粘度和红细胞膜成分变化,建立两者相关性的研究方法。将18例气虚血瘀型冠心病心绞痛患者、13例健康老人和10例健康青年人分为冠心病人组、健康老人对照组和青年对照组,测定血浆中的生化指标、全血粘度、血浆粘度、红细胞变形性、红细胞膜上的胆固醇含量、唾液酸含量、巯基含量、SOD活性、MDA含量、Na+-K+-ATP酶活力、膜蛋白组成以及激光共聚焦显微镜观察红细胞膜形态变化,以探讨其致病机制。
结果：(1)与健康人比较,气虚血瘀型冠心病心绞痛患者全血粘度、血浆粘度均高于健康人(P<0.01,P<0.05),红细胞变形能力明显降低(P<0.01);血浆和红细胞膜上胆固醇含量明显升高(P<0.01,P<0.05)；而膜上唾液酸含量、巯基含量显著降低(P<0.01,P<0.01);尽管Na+-K+-ATP酶活性和SOD活性降低,丙二醛含量升高,但无统计学意义；(2)与青年人比较,气虚血瘀型冠心病心绞痛患者红细胞形态和骨架发生变化,F-actin含量降低并呈解聚状态；包括带1蛋白、带3蛋白、带4.1蛋白、带4.2蛋白、带5蛋白、原肌球调节蛋白和带6蛋白百分含量均显著降低,健康老人组带1、带3、带4.1、原肌球调节蛋白百分含量均显著高于气虚血瘀型冠心病人组的蛋白含量。
结论：以老龄大鼠和青年大鼠为研究对象,从红细胞膜组分变化,建立了红细胞膜组分与血液粘度相关性所涉及部分指标的研究方法。气虚血瘀型冠心病心绞痛患者的全血粘度、血浆粘度显著升高,红细胞变形能力明显降低,其机制可能是由于红细胞表面唾液酸含量和巯基含量减少,膜胆固醇含量增多、红细胞膜骨架F-actin解聚,膜蛋白组成发生变化,从而导致抗氧化能力低下,膜流动性降低。
Objectives:The coronary heart disease patients who were qi deficiency to blood stasis were observed in this article. The mechanism of the decreasement of red cell deformability and membrane fluidity of coronary heart disease patients were studied through the change of hemorheology and ingredient of erythrocyte membrane. The mechanism of blood stasis that happened in erythrocyte membrane was further looking for. And the results could be as the reference for diagnosis and treatment of coronary heart disease patients who were qi deficiency to blood stasis. The technology platform was established for studying of mechanism and target spot of action.
Methods:The senile rats and young rats were observed in this article. Erythrocyte membrane was prepared. The change of blood viscosity and ingredient of erythrocyte membrane were determined. The research method for the relativity of them was established. Eighteen coronary heart disease patients who were qi deficiency to blood stasis, thirteen healthy old people and ten healthy young people were divided into coronary patient group and healthy old people control group and healthy young people control group. Many indexes such as biochemical indicator of plasma, whole blood viscosity, plasma viscosity, erythrocyte deformability and the content of cholesterol, sialic acid, hydrosulphonyl, MDA, activity of SOD, Na+-K+-ATP enzyme activity of erythrocyte membrane, constitute of membrane protein, change of form of erythrocyte membrane under laser scanning confocal fluorescence microscope were determined. The mechanism of causing blood stasis was investigated in this article.
Results:(1) The whole blood viscosity and plasma viscosity of coronary patient are significantly higher than that of the healthy people (P<0.01,P<0.05); The red cell deformability index is lower than that of healthy people (P<0.01); The contents of cholesterol in erythrocyte membrane and plasma are significantly higher than that of the healthy people (P<0.01,P<0.05). The contents of sialic acid and hydrosulphonyl in erythrocyte membrane are significantly lower than that of the healthy people (P<0.01,P<0.01). SOD and Na+-K+-ATP enzyme activity of erythrocyte membrane are decreasing and the content of MDA is increasing. But there are not statistically significant. (2) Compare with the young people, there are some changes of red cell morphology and membrane skeleton in coronary heart disease patients who were qi deficiency to blood stasis. The content of F-actin is decreased and F-actin is depolymerization. The percentage composition of band 1 protein, band 3 protein, band 4.1 protein, band 4.2 protein, band 5 protein, band 6 protein and tropomodulin of coronary patients are significantly lower than that of the healthy young people. The percentage composition of band 1 protein, band 3 protein and band 4.2 protein of the healthy old people are significantly higher than that of coronary patients.
Conclusions:The senile rats and young rats were as object of study. The research method for the relativity of blood viscosity and ingredient of erythrocyte membrane was established. The whole blood viscosity and plasma viscosity are increased significantly and the red cell deformability is decreased distinctly. The mechanism of decreasing antioxidant ability and membrane fluidity may has relationship with the following points:increasing the content of sialic acid and hydrosulphonyl, reducing the content of cholesterol in erythrocyte membrane, depolymerization of F-actin and the change of composition of membrane protein.
引文
[1]秦建国.胸痹心痛病机新论[J].辽宁中医杂志,2004,31(10)：815-816.
[2]杨利,邓铁涛.“冠心三论”[J].湖南中医药导报,2004,10(6)：8-10.
[3]许从真.冠心病心绞痛辨证论治[J].浙江中西医结合杂志,2003,13(1)：59.
[4]吕芳芳.冠心病心绞痛不同证型与血液流变关系的探讨[J].北京中医,2004,23(6)：327.
[5]宫爱华,孙素琴,荣文平.心痛滴剂治疗冠心病心绞痛的实验研究[J].辽宁中医杂志,2004,31(5)：434.
[6]邵莹.益气活血法治疗冠心病心绞痛临床观察[J].现代中西医结合杂志,2006,15(4)：422.
[7]陈平.补阳还五汤治疗冠心病心绞痛临床观察[J].医学信息,2005,18(8)：1184.报,2007,13(12)：77-78
[8]庄德成.“活血通痹汤”治疗冠心病心绞痛气虚血瘀证42例临床观察[J].江苏中医药,2002(10)：23.
[9]李红梅.益气活血汤治疗冠心病心绞痛疗效观察[J].辽宁中医杂志,2005,32(1)：40.
[10]毛静远,虞东玲,张宇,等.黄芪丹参滴丸治疗冠心病心绞痛(气虚血瘀证)的临床疗效[J].中国新药杂志,2007,3：4-5.
[11]王英.麝香救心滴丸和养心氏片治疗冠心病心绞痛(气虚血瘀证)的疗效比较[J].吉林医学,2007,(5)
[12]薛一涛,吴彤,刘伟.从血管内皮功能探讨情志因素与冠心病的关系[J].山东中医杂志,2005,24(6)：323-324.
[13]鲁明源.湿热体质与冠心病[J].山东中医药大学学报,2003,27(1)：16-20.
[14]胡冬裴.胸痹古今证型归类研究[J].上海中医药大学学报,2004,18(4)：8-10.
[15]林晓忠,吴焕林,严夏,等.邓铁涛教授论治冠心病规律探要[J].中医药学刊,2001,19(5)：412-414.
[16]曹洪欣,张华敏.气虚血瘀与冠心病发病机理辨识[J].中医药学刊.2001,19(6)：544-545
[17]李洁,解品启,王英震.冠心病心绞痛从痰瘀论治[J].陕西中医.2001,22(2)：96-97.
[18]于涛,曹洪欣.胸痹(冠心病)病机演变探微[J].中医药信息,2004,21(2)：1-3.
[19]周承志 唐娟.冠心病从肝论治五法[J].湖北中医杂志,2001,23(10)：19-24.
[20]刘绪银.冠心病从胆论治[J].甘肃中医,1997,10(4)：3-4.
[21]张毅,范平.冠心病从肺论治探析[J].山东中医杂志,1998,17：5-7.
[22]朱喜英,刘龙民,陈建杰.论冠心病发病与胃之关系[J].云南中医学院学报.2001,(3)：29-33.
[23]安辉.脾胃与冠心病关系初探[J].湖南中医学院学报.1995,15(2)：11-12.
[24]黄惠勇.冠心病病机的阶段论[J].中国医药学报.1996,11(2)：21-23.
[25]王文波,程小燕.冠心病心绞痛有关气虚血瘀病机及其证治的研究进展.中医药导
[26]梁煜,林代华,王清.气虚血瘀是冠心病的病机关键释义[J].中医药学刊,2003,21(4)：588-589.
[27]渠慎成,王晓红,陈波.血瘀证的本质初探.中医药信息,2007,6(2)：18-19.
[28]田牛,李玉珍,刘育英.血瘀证的微循环研究.中国中西医结合杂志,2001,4(3)：55.
[29]回学英,雷慧,杜会博,等.微循环障碍的中医认识及治疗现状.现代中西医结合杂志,2009年,24：41-42.
[30]壮梦今.临床诊断血.瘀证的体会.吉林中医药,2003,12：11-12.
[31]陈可冀,马晓昌.关于传统血瘀证的现代分类.中国中西医结合杂志,2000,20(7)：487.
[32]项颗,孙莉.轻度认知功能障碍血瘀证与血流变、TXB2、6-Keto-PGF1α相关性研究.中国现代医生,2010,48(22)：34-36.
[33]何庭宇,曾伟英,梁智恒,等.不同年龄与疾病血液流变学特征[J].中国血液流变学杂志,2004,14(1)：68-71.
[34]杜美华,黄本成,王秀丽,等.不同年龄体检者血.液流变学几项指标分析[J].中国血液流变学杂志,2000,10(1)：62.
[35]张丹凤,夏向南.血液流变学与增龄的关系[J].现代医药卫生,2005,21(8)：896-897.
[36]袁长瑞.血瘀证微循环障碍与活血化瘀[J].中医药研究,1998,14(4)：15-19.
[37]秦任甲.血液流变学及其医学应用[M].广西：广西师范大学出版社,1999：243.
[38]赵宁侠,郭瑞林,任秦有,等.艾灸三阴交穴对健康人血液流变学及红细胞聚集指数的影响[J].云南中医学院学报,2003,26(4)：31-34.
[39]刘军莲,宋剑南.中医血瘀证本质研究概况[J].辽宁中医杂志,2006,33(9)：1061-1063
[40]董振华.祝谌予治疗糖尿病经验举要[J].中国医药学报,1993,8(1)：43-45.
[41]曹雪明,张泉,郑重,等.冠心病中医证型与血液流变学相关性探讨[J].中国中医急症,2006,15(11)：1242-1243
[42]王桂玲,王磊,王忠爱,等.冠心病的中医辨证分型与血液流变学指标的关系[J].实用心电学杂志,2007,16(2)：124-126.
[43]刘德恒,许真真,郭伟聪,等.冠心病心绞痛395例中医症候特点探讨[J].中医杂志,1995,36(10)：617.
[44]孙锡印,段学忠.冠心病中医证型间血液流变性的异同及辨治其影响[J].中医药研究,1997,(1)：1-2.
[45]胡少锋,马金波.参麦注射液对心绞痛患者血液流变学的影响[J].现代中西医结合杂志,10(21)：2025.
[46]杨春华,唐建清,刘桂香.冠脉宁对老年冠心病心绞痛血液流变学及血脂的影响[J].中国中医急症,9(5)：189.
[47]朱秋玲,陈祥君.化瘀胶囊对冠心病血痕证患者血液流变学及体外血栓形成的影响[J].现代中西医结合杂志,2005,14(10)：1268.
[48]翟虹燕,张永忠.冠心病气病致瘀证血液流变学及心功能特征临床实验观察[J].贵阳中医学院学报,1997,19(1)：19.
[49]刘成玉,等.冠心病患者红细胞变形能力与红细胞膜脂质成分和PAP-AH活性关系的研究[J].临床心血管病杂志,1995,11(4)：199.
[50]武阳丰,周北凡,李莹,等.缺血性心血管病：一个反映血脂异常潜在危险的新指标[J].中华心血管病杂志,2004,32(2)：173-176.
[51]He J, Gu D, Wu X, et al. Major causes of death among men and women in China[J]. N Engl J Med,2005,353 (11):1124-1134.
[52]张敏,游芳,陈春锦,等.动脉硬化性脑梗死患者血液流变学和血脂测定[J].现代中西医结合杂志,2005,14(9)：1198-1199.
[53]邹本勤.肖方喜.工向荣.脑梗死患者急性期血液流变性及血糖的变化[J].微循环学杂志.2004,13(4)：63-64.
[54]杨敦山.刘丽英.动脉硬化性脑梗死的血脂分析[J].微循环学杂志,2004,13(2)：64
[55]刘久波.杨青山.黄平.几种老年性疾病患者血液流变性及血脂改变[J].微循环学杂志.2004,13(4)：40-41.
[56]Li XN, Grenett HE, Benza RL, et al. Genotypeciptional regulation of PA Ⅱ expression by hypertridemeic LDL and Lp(a) inculture human endothelial cells[J]. Arterioscler Thromb VascBiol,1997,17(11):3215-3223.
[57]Cui Y, Blumenthal RS, Flaws JA, et al. Non high density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality[J]. Arch Intern Med, 2001,161(11):1413-1419.
[58]赵文化,张坚,由悦,等.中国18岁及以上人群血脂异常流行特点研究[J].中华预防医学杂志,2005,39(5)：306-310.
[59]武阳丰,赵冬,周北凡,等.中国人群血脂异常诊治和分层方案的研究[J].中华心血管病杂志,2007,35(5)：428-433.
[60]王薇,赵冬,刘静,等.中国35～64岁人群心血管病危险因素与发病危险预测模型的前瞻性研究[J].中华心血管病杂志,2003,31(12)：902-908.
[61]陈国良,刘立伟,谢爽,等.高密度脂蛋白胆固醇代谢及其对冠心病影响的研究进展[J].心血管病学进展,2010,31(3)：360-363.
[62]FranceschiniG. Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease[J].Am JCardio,1 2001,88:9-13.
[63]Johansen O,Abdelnoor M,Brekke M, et al. Predictors ofrestenosis after coronary angioplasty.A study on demographic andmetabolic variables [J]. Scand Cardiovasc J, 2001,5:86-91.
[64]李莹,陈志红,周北凡,等.血脂和脂蛋白水平对我国中年人群缺血性心血管病事件的预测作用[J].中华心血管病杂志,2004,32(7)：643-647.
[65]胡翊群,胡建达,等.临床血液学检验第二版[M],中国医药科技出版社
[66]张健,张进忠,张积仁,等.N-糖基化抑制对胶质瘤细胞膜流动性的研究[J].中华神经外科杂志,2000,16(3)：174-176.
[67]李绍顺.唾液酸及其衍生物的生物学研究进展[J].药学进展,1997,21(2)：70-75.
[68]张春明,刘艺,杨鸿昌.唾液酸的生物学功能及临床意义[J].哈尔滨医科大学学报,1990,24(6)：500.
[69]张惟杰.唾液酸[J].生物化学杂志,1986,2(5)：1.
[70]Shu Chien, Gborge W Cooper, KubgMingjin, eta.l Nacetyl neurminic acid deficiency in erythrocyte membrane:biophysical and biochemical correlates [J]. Blood,1974,43 (3):445.
[71]Hobarth K, Hofbauer J, Fang - Kircher S. Plasma sialic acid in patient with prostate cancer [J]. British Journal of Urology,1993,72:621-624.
[72]唐建华,卢义钦.红细胞膜的磷脂代谢[J].生理科学进展,1990,21：31-35.
[73]王浩然.糖尿病红细胞膜脂质成分改变与红细胞变形能力的关系[J].中华医学杂志,1991,(1)：21
[74]An XL, Takakuwa Y, Nunomura W, et al. Modulation of band 3-ankyrin interaction by protein 4.1.Functional implications in regulation of erythrocyte membrane mechanical properties [J]. Biol Chem,1996,271 (52):33187-91.
[75]蒋玮莹,田兴亚.G6PD缺乏患者红细胞膜ATP酶活性研究[J].中国病理生理杂志,1991,7：24-26.
[76]郭胜祥,陈秀桂,杜军英,等.人体衰老与血液巯基含量关系的研究.老年学杂志,1994,14(1)：45.
[77]卢义钦,刘俊凡.红细胞膜蛋白与膜骨’架.生命科学研究,2005,9(4)：283-291
[78]彭溦雁,王翔,高玮,等.红细胞膜带4.2蛋白的结构与功能.细胞生物学杂志,2007,29：687-691
[79]余果宇,田兴亚.红细胞膜带3蛋白酪氨酸磷酸化的研究进展.国外医学临床生物化学与检验学分册,2004,25(2)：169-171
[80]Barbul A,Zipser Y,NachlesA,et al.Deoxygenation and elevation of intracellular magnesium induce tyrosine phosphorylation of band 3 in human erythrocytes.FEBS Lett,1999,455(1-2):87-91.
[81]BETUL Y M, YAPISLAR H, AYDOGAN S, et al. Lipid peroxidation and deformability of red bllood cells in experimental sepisin rats the protective effects of melatonin [J]. Clinical hemorheology and microcirculation,2004,30:77-82.
[82]曹东辉,杨志新.中医辨证治疗冠心病临床总结[J].中国现代药物应用,2005,4(9)：138-139.
[83]宋群利,柯学,王砚颖,等.益气活血汤治疗气虚血瘀型冠心病慢性心衰临床观察[J].湖北中医杂志,2010,32(7)：39-40.
[84]孙艺军,冠心病的基本病机为气虚血瘀.长春中医药大学学报,2011,27(1)：51-52.
[85]刘德桓,许真真,郭伟聪.冠心病心绞痛395例中医证型特点探讨.中医杂志,1995,10：617.
[86]陈忠良.病证结合冠心病心绞痛气虚血瘀证研究[D].北京：中国中医科学院,2004.
[87]郭志华.冠心病心绞痛2432例中医辨证分型综合统计分析[J].湖南中医杂志,1998,14(2)：7-8.
[88]李民,赵施竹.心脑血管疾病患者脂蛋白a和红细胞变形性分析[J].心血管康复医学杂志,2008,17(1)：15-16.
[89]KamadaT,Angera K.Lower levels of erythrocyte membrane fluidity in diabetic patients[J]. Diabetes,1983,32:585.
[90]Lijin P,Petro V.Cholesterol moduation of transmembrane cation transport systems in human erythrocytes[J].BiochemMolmeb,1995,56(1):52.
[91]张世民.复合糖末端唾液酸的双重性—受体作用和掩蔽作用[J].生命的化学,1991,11(5)：17-19.
[92]Toyoshima M, Nakajima M, Yamori T, et al. Purification and characterization of the plate-letaggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26[J].Cancer Res,1995,55:767-773.
[93]Dodon M D, Quash G A.The antigenecity of asialated IgG:its relationship to rheumatoid factor [J].Immunology,1981,42:401-408.
[94]Najiri H, Takaku F, Teri Y, et al. Ganglioside GM3;an acidic membrane component that increases during macrophage like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemia cell lines HL60 and U937[J]. Proc Natl Acad Sci USA,1986,83:782-786.
[95]Yogeeswaran G, Salk P L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines [J]. Science,1981, 212:1514-1516.
[96]Balduini C L, Sinegaglia F, Ascari E, et al.Aging of rabit red cellsin vivo:Membrane modifications and their possible role in red cell survivalin vivo[J]. Acta Haematol,1981,65:263-269.
[97]王云起,李国有,等.人红细胞老化过程中膜表面唾液酸变化的免疫AFM研究[J].电子显微学报,2007,26(1)：60-63.
[98]张京立,陶国枢,伊振宣,等.老年人红细胞电泳时间变化观察[J].实用老年医学,2003,17(5)：279-280.
[99]Allain P,Olivier E,Le Bouil A,et al.Increase of sialic acid concentration in the plasma of patients with coronary disease·Presse Med,1996,25(3):96-98.
[100]王翔,宋关斌,吴泽志,等.膜蛋白巯基的氧化还原修饰对红细胞膜粘弹性的影响[J].生物物理学报,1997,13(1)：144-147.
[101]陶国枢.四项衰老指标的探讨[J].中华老年医学杂志,1988,7：167.
[102]RauchovH, Ledvinkovy The effects of lipid peroxidation on the activity of variousmembrane -boundATPases in rat kidney[J]·J BiochemCell Biol,1995,Mar 27(3):251-253.
[103]杨尚武,苟文丽,文梦灵.子痫前期患者钠钾ATP酶活性及与脂质过氧化关系的研究[J].中国热带医学,2006,6(5)：845.
[104]黄振倩,张瑶珍,张东华,等.穿心莲提取物F0134抗红细胞膜氧化损伤的实验研究[J].同济医科大学学报,1999,28(4)：332-334.
[105]固本财,马建林,田元,等.高胆固醇饲料诱导红细胞膜脂蛋白、脂质过氧化和膜流动性的改变[J].微循环学杂志,1996,6(3)：41-42.
[106]Amos W B, White J G.How the confocal laser scanning microscope entered biological research[J].Biology of the Cell,2003,95:335-342.
[107]赵启韬,苗俊英.激光共聚焦显微镜在生物医学研究中的应用[J].北京生物医学工程,2003,22(1)：52-54.
[108]Rachita M, Sushil P, Uday K.Confocal laser microscope [J].Indian J Dermatol Venereol Leprol,2006,72(5):394-397.
[109]Diaspro A, Annunziata S, RaimondoM, et al.Asingle-pinhole confocal laser scanning microscope for 3-D imaging of biostructures [J]. IEEE Eng Med Biol.,1999, 18:106-110.
[110]Zimprich F, Ashworth R, Bolsover S.Real-time measurements of calcium dynamics in neurons developing in situ within zebrafish embryos[J].Pflugers Arch, 1998,36:489-493.
[111]宋怀宇,赵启韬,王万忠.激光共聚焦显微镜对肝组织纤维化程度的荧光定量分析[J].中华消化杂志,2003,23(7)：437-438.
[112]Schuurhuis DH, Ioan-Facsinay A, Nagelkerken B, et al.Anti-genantibody immune complexes empower dendritic cells to effi-ciently prime specific CD8+CTLresponses in vivo[J].J Immunol,200,168(5):2240-2242.
[113]Iwasaki A, Kelsall BL.Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein(MIP)-3alpha,,MIP-3beta and secondary lymphoid organ chemokine[J].J Exp Med,2000,191(8):1381-1382.
[114]张赞,程光,韩卫宁,等.超抗原对NK细胞CD226分子表达与功能的调节[J].细胞与分子免疫学杂志,2006,22(1)：4-5.
[115]刘峰,姚咏明,徐姗,等.高迁移率族蛋白B1对小鼠巨噬细胞免疫功能影响的受体机制[J].中华实验外科杂志,2007,24(2)：166.
[116]谭玉珍,王海杰,张文彩,等.免疫球蛋白超家族黏附分子在淋巴管和不同血管内皮细胞的表达[J].解剖学报,2006,37(1)：52-53.
[117]张赞,程光,韩卫宁,等.超抗原对NK细胞亚群凋亡诱导配体表达与功能的调节[J].免疫学杂志,2006,22(3)：239-240.
[118]朱昌来,林琳,张天一.肿瘤源性热休克蛋白gp96诱导淋巴细胞反应及其抗肿瘤效应[J].中国免疫学杂志,2007,23(3)：234-235.
[119]张姿,刘佳佳,姚富丽,等.ONO-AE-248诱导的中性粒细胞非凋亡性程序化细胞死亡的形态学变化[J].细胞与分子免疫学杂志,2007,23(5)：413.
[120]张馨予,李晓眠,杨洁.医学免疫学研究中激光共聚焦显微镜的应用.天津医科大学学报,2008,14(2)：267-273.
[121]Hamrah P, Zhang Q, Liu Y, et a 1. Novel characterization of MHC class II-negative population of resident corneal Langerhans celltype dendritic cells[J].Invest Ophthalmol Vis Sci,2002,43(3):639-640.
[122]Stoll S, Delon J, BrotzTM, et al. Dynamic imagingofTcell-dendritic cell interaction in lymph nodes[J].Science,2002,296(5574):1873-1874.
[2]杨利,邓铁涛.“冠心三论”[J].湖南中医药导报,2004,10(6)：8-10.
[3]许从真.冠心病心绞痛辨证论治[J].浙江中西医结合杂志,2003,13(1)：59.
[4]吕芳芳.冠心病心绞痛不同证型与血液流变关系的探讨[J].北京中医,2004,23(6)：327.
[5]宫爱华,孙素琴,荣文平.心痛滴剂治疗冠心病心绞痛的实验研究[J].辽宁中医杂志,2004,31(5)：434.
[6]邵莹.益气活血法治疗冠心病心绞痛临床观察[J].现代中西医结合杂志,2006,15(4)：422.
[7]陈平.补阳还五汤治疗冠心病心绞痛临床观察[J].医学信息,2005,18(8)：1184.报,2007,13(12)：77-78
[8]庄德成.“活血通痹汤”治疗冠心病心绞痛气虚血瘀证42例临床观察[J].江苏中医药,2002(10)：23.
[9]李红梅.益气活血汤治疗冠心病心绞痛疗效观察[J].辽宁中医杂志,2005,32(1)：40.
[10]毛静远,虞东玲,张宇,等.黄芪丹参滴丸治疗冠心病心绞痛(气虚血瘀证)的临床疗效[J].中国新药杂志,2007,3：4-5.
[11]王英.麝香救心滴丸和养心氏片治疗冠心病心绞痛(气虚血瘀证)的疗效比较[J].吉林医学,2007,(5)
[12]薛一涛,吴彤,刘伟.从血管内皮功能探讨情志因素与冠心病的关系[J].山东中医杂志,2005,24(6)：323-324.
[13]鲁明源.湿热体质与冠心病[J].山东中医药大学学报,2003,27(1)：16-20.
[14]胡冬裴.胸痹古今证型归类研究[J].上海中医药大学学报,2004,18(4)：8-10.
[15]林晓忠,吴焕林,严夏,等.邓铁涛教授论治冠心病规律探要[J].中医药学刊,2001,19(5)：412-414.
[16]曹洪欣,张华敏.气虚血瘀与冠心病发病机理辨识[J].中医药学刊.2001,19(6)：544-545
[17]李洁,解品启,王英震.冠心病心绞痛从痰瘀论治[J].陕西中医.2001,22(2)：96-97.
[18]于涛,曹洪欣.胸痹(冠心病)病机演变探微[J].中医药信息,2004,21(2)：1-3.
[19]周承志 唐娟.冠心病从肝论治五法[J].湖北中医杂志,2001,23(10)：19-24.
[20]刘绪银.冠心病从胆论治[J].甘肃中医,1997,10(4)：3-4.
[21]张毅,范平.冠心病从肺论治探析[J].山东中医杂志,1998,17：5-7.
[22]朱喜英,刘龙民,陈建杰.论冠心病发病与胃之关系[J].云南中医学院学报.2001,(3)：29-33.
[23]安辉.脾胃与冠心病关系初探[J].湖南中医学院学报.1995,15(2)：11-12.
[24]黄惠勇.冠心病病机的阶段论[J].中国医药学报.1996,11(2)：21-23.
[25]王文波,程小燕.冠心病心绞痛有关气虚血瘀病机及其证治的研究进展.中医药导
[26]梁煜,林代华,王清.气虚血瘀是冠心病的病机关键释义[J].中医药学刊,2003,21(4)：588-589.
[27]渠慎成,王晓红,陈波.血瘀证的本质初探.中医药信息,2007,6(2)：18-19.
[28]田牛,李玉珍,刘育英.血瘀证的微循环研究.中国中西医结合杂志,2001,4(3)：55.
[29]回学英,雷慧,杜会博,等.微循环障碍的中医认识及治疗现状.现代中西医结合杂志,2009年,24：41-42.
[30]壮梦今.临床诊断血.瘀证的体会.吉林中医药,2003,12：11-12.
[31]陈可冀,马晓昌.关于传统血瘀证的现代分类.中国中西医结合杂志,2000,20(7)：487.
[32]项颗,孙莉.轻度认知功能障碍血瘀证与血流变、TXB2、6-Keto-PGF1α相关性研究.中国现代医生,2010,48(22)：34-36.
[33]何庭宇,曾伟英,梁智恒,等.不同年龄与疾病血液流变学特征[J].中国血液流变学杂志,2004,14(1)：68-71.
[34]杜美华,黄本成,王秀丽,等.不同年龄体检者血.液流变学几项指标分析[J].中国血液流变学杂志,2000,10(1)：62.
[35]张丹凤,夏向南.血液流变学与增龄的关系[J].现代医药卫生,2005,21(8)：896-897.
[36]袁长瑞.血瘀证微循环障碍与活血化瘀[J].中医药研究,1998,14(4)：15-19.
[37]秦任甲.血液流变学及其医学应用[M].广西：广西师范大学出版社,1999：243.
[38]赵宁侠,郭瑞林,任秦有,等.艾灸三阴交穴对健康人血液流变学及红细胞聚集指数的影响[J].云南中医学院学报,2003,26(4)：31-34.
[39]刘军莲,宋剑南.中医血瘀证本质研究概况[J].辽宁中医杂志,2006,33(9)：1061-1063
[40]董振华.祝谌予治疗糖尿病经验举要[J].中国医药学报,1993,8(1)：43-45.
[41]曹雪明,张泉,郑重,等.冠心病中医证型与血液流变学相关性探讨[J].中国中医急症,2006,15(11)：1242-1243
[42]王桂玲,王磊,王忠爱,等.冠心病的中医辨证分型与血液流变学指标的关系[J].实用心电学杂志,2007,16(2)：124-126.
[43]刘德恒,许真真,郭伟聪,等.冠心病心绞痛395例中医症候特点探讨[J].中医杂志,1995,36(10)：617.
[44]孙锡印,段学忠.冠心病中医证型间血液流变性的异同及辨治其影响[J].中医药研究,1997,(1)：1-2.
[45]胡少锋,马金波.参麦注射液对心绞痛患者血液流变学的影响[J].现代中西医结合杂志,10(21)：2025.
[46]杨春华,唐建清,刘桂香.冠脉宁对老年冠心病心绞痛血液流变学及血脂的影响[J].中国中医急症,9(5)：189.
[47]朱秋玲,陈祥君.化瘀胶囊对冠心病血痕证患者血液流变学及体外血栓形成的影响[J].现代中西医结合杂志,2005,14(10)：1268.
[48]翟虹燕,张永忠.冠心病气病致瘀证血液流变学及心功能特征临床实验观察[J].贵阳中医学院学报,1997,19(1)：19.
[49]刘成玉,等.冠心病患者红细胞变形能力与红细胞膜脂质成分和PAP-AH活性关系的研究[J].临床心血管病杂志,1995,11(4)：199.
[50]武阳丰,周北凡,李莹,等.缺血性心血管病：一个反映血脂异常潜在危险的新指标[J].中华心血管病杂志,2004,32(2)：173-176.
[51]He J, Gu D, Wu X, et al. Major causes of death among men and women in China[J]. N Engl J Med,2005,353 (11):1124-1134.
[52]张敏,游芳,陈春锦,等.动脉硬化性脑梗死患者血液流变学和血脂测定[J].现代中西医结合杂志,2005,14(9)：1198-1199.
[53]邹本勤.肖方喜.工向荣.脑梗死患者急性期血液流变性及血糖的变化[J].微循环学杂志.2004,13(4)：63-64.
[54]杨敦山.刘丽英.动脉硬化性脑梗死的血脂分析[J].微循环学杂志,2004,13(2)：64
[55]刘久波.杨青山.黄平.几种老年性疾病患者血液流变性及血脂改变[J].微循环学杂志.2004,13(4)：40-41.
[56]Li XN, Grenett HE, Benza RL, et al. Genotypeciptional regulation of PA Ⅱ expression by hypertridemeic LDL and Lp(a) inculture human endothelial cells[J]. Arterioscler Thromb VascBiol,1997,17(11):3215-3223.
[57]Cui Y, Blumenthal RS, Flaws JA, et al. Non high density lipoprotein cholesterol level as a predictor of cardiovascular disease mortality[J]. Arch Intern Med, 2001,161(11):1413-1419.
[58]赵文化,张坚,由悦,等.中国18岁及以上人群血脂异常流行特点研究[J].中华预防医学杂志,2005,39(5)：306-310.
[59]武阳丰,赵冬,周北凡,等.中国人群血脂异常诊治和分层方案的研究[J].中华心血管病杂志,2007,35(5)：428-433.
[60]王薇,赵冬,刘静,等.中国35～64岁人群心血管病危险因素与发病危险预测模型的前瞻性研究[J].中华心血管病杂志,2003,31(12)：902-908.
[61]陈国良,刘立伟,谢爽,等.高密度脂蛋白胆固醇代谢及其对冠心病影响的研究进展[J].心血管病学进展,2010,31(3)：360-363.
[62]FranceschiniG. Epidemiologic evidence for high-density lipoprotein cholesterol as a risk factor for coronary artery disease[J].Am JCardio,1 2001,88:9-13.
[63]Johansen O,Abdelnoor M,Brekke M, et al. Predictors ofrestenosis after coronary angioplasty.A study on demographic andmetabolic variables [J]. Scand Cardiovasc J, 2001,5:86-91.
[64]李莹,陈志红,周北凡,等.血脂和脂蛋白水平对我国中年人群缺血性心血管病事件的预测作用[J].中华心血管病杂志,2004,32(7)：643-647.
[65]胡翊群,胡建达,等.临床血液学检验第二版[M],中国医药科技出版社
[66]张健,张进忠,张积仁,等.N-糖基化抑制对胶质瘤细胞膜流动性的研究[J].中华神经外科杂志,2000,16(3)：174-176.
[67]李绍顺.唾液酸及其衍生物的生物学研究进展[J].药学进展,1997,21(2)：70-75.
[68]张春明,刘艺,杨鸿昌.唾液酸的生物学功能及临床意义[J].哈尔滨医科大学学报,1990,24(6)：500.
[69]张惟杰.唾液酸[J].生物化学杂志,1986,2(5)：1.
[70]Shu Chien, Gborge W Cooper, KubgMingjin, eta.l Nacetyl neurminic acid deficiency in erythrocyte membrane:biophysical and biochemical correlates [J]. Blood,1974,43 (3):445.
[71]Hobarth K, Hofbauer J, Fang - Kircher S. Plasma sialic acid in patient with prostate cancer [J]. British Journal of Urology,1993,72:621-624.
[72]唐建华,卢义钦.红细胞膜的磷脂代谢[J].生理科学进展,1990,21：31-35.
[73]王浩然.糖尿病红细胞膜脂质成分改变与红细胞变形能力的关系[J].中华医学杂志,1991,(1)：21
[74]An XL, Takakuwa Y, Nunomura W, et al. Modulation of band 3-ankyrin interaction by protein 4.1.Functional implications in regulation of erythrocyte membrane mechanical properties [J]. Biol Chem,1996,271 (52):33187-91.
[75]蒋玮莹,田兴亚.G6PD缺乏患者红细胞膜ATP酶活性研究[J].中国病理生理杂志,1991,7：24-26.
[76]郭胜祥,陈秀桂,杜军英,等.人体衰老与血液巯基含量关系的研究.老年学杂志,1994,14(1)：45.
[77]卢义钦,刘俊凡.红细胞膜蛋白与膜骨’架.生命科学研究,2005,9(4)：283-291
[78]彭溦雁,王翔,高玮,等.红细胞膜带4.2蛋白的结构与功能.细胞生物学杂志,2007,29：687-691
[79]余果宇,田兴亚.红细胞膜带3蛋白酪氨酸磷酸化的研究进展.国外医学临床生物化学与检验学分册,2004,25(2)：169-171
[80]Barbul A,Zipser Y,NachlesA,et al.Deoxygenation and elevation of intracellular magnesium induce tyrosine phosphorylation of band 3 in human erythrocytes.FEBS Lett,1999,455(1-2):87-91.
[81]BETUL Y M, YAPISLAR H, AYDOGAN S, et al. Lipid peroxidation and deformability of red bllood cells in experimental sepisin rats the protective effects of melatonin [J]. Clinical hemorheology and microcirculation,2004,30:77-82.
[82]曹东辉,杨志新.中医辨证治疗冠心病临床总结[J].中国现代药物应用,2005,4(9)：138-139.
[83]宋群利,柯学,王砚颖,等.益气活血汤治疗气虚血瘀型冠心病慢性心衰临床观察[J].湖北中医杂志,2010,32(7)：39-40.
[84]孙艺军,冠心病的基本病机为气虚血瘀.长春中医药大学学报,2011,27(1)：51-52.
[85]刘德桓,许真真,郭伟聪.冠心病心绞痛395例中医证型特点探讨.中医杂志,1995,10：617.
[86]陈忠良.病证结合冠心病心绞痛气虚血瘀证研究[D].北京：中国中医科学院,2004.
[87]郭志华.冠心病心绞痛2432例中医辨证分型综合统计分析[J].湖南中医杂志,1998,14(2)：7-8.
[88]李民,赵施竹.心脑血管疾病患者脂蛋白a和红细胞变形性分析[J].心血管康复医学杂志,2008,17(1)：15-16.
[89]KamadaT,Angera K.Lower levels of erythrocyte membrane fluidity in diabetic patients[J]. Diabetes,1983,32:585.
[90]Lijin P,Petro V.Cholesterol moduation of transmembrane cation transport systems in human erythrocytes[J].BiochemMolmeb,1995,56(1):52.
[91]张世民.复合糖末端唾液酸的双重性—受体作用和掩蔽作用[J].生命的化学,1991,11(5)：17-19.
[92]Toyoshima M, Nakajima M, Yamori T, et al. Purification and characterization of the plate-letaggregating sialoglycoprotein gp44 expressed by highly metastatic variant cells of mouse colon adenocarcinoma 26[J].Cancer Res,1995,55:767-773.
[93]Dodon M D, Quash G A.The antigenecity of asialated IgG:its relationship to rheumatoid factor [J].Immunology,1981,42:401-408.
[94]Najiri H, Takaku F, Teri Y, et al. Ganglioside GM3;an acidic membrane component that increases during macrophage like cell differentiation can induce monocytic differentiation of human myeloid and monocytoid leukemia cell lines HL60 and U937[J]. Proc Natl Acad Sci USA,1986,83:782-786.
[95]Yogeeswaran G, Salk P L. Metastatic potential is positively correlated with cell surface sialylation of cultured murine tumor cell lines [J]. Science,1981, 212:1514-1516.
[96]Balduini C L, Sinegaglia F, Ascari E, et al.Aging of rabit red cellsin vivo:Membrane modifications and their possible role in red cell survivalin vivo[J]. Acta Haematol,1981,65:263-269.
[97]王云起,李国有,等.人红细胞老化过程中膜表面唾液酸变化的免疫AFM研究[J].电子显微学报,2007,26(1)：60-63.
[98]张京立,陶国枢,伊振宣,等.老年人红细胞电泳时间变化观察[J].实用老年医学,2003,17(5)：279-280.
[99]Allain P,Olivier E,Le Bouil A,et al.Increase of sialic acid concentration in the plasma of patients with coronary disease·Presse Med,1996,25(3):96-98.
[100]王翔,宋关斌,吴泽志,等.膜蛋白巯基的氧化还原修饰对红细胞膜粘弹性的影响[J].生物物理学报,1997,13(1)：144-147.
[101]陶国枢.四项衰老指标的探讨[J].中华老年医学杂志,1988,7：167.
[102]RauchovH, Ledvinkovy The effects of lipid peroxidation on the activity of variousmembrane -boundATPases in rat kidney[J]·J BiochemCell Biol,1995,Mar 27(3):251-253.
[103]杨尚武,苟文丽,文梦灵.子痫前期患者钠钾ATP酶活性及与脂质过氧化关系的研究[J].中国热带医学,2006,6(5)：845.
[104]黄振倩,张瑶珍,张东华,等.穿心莲提取物F0134抗红细胞膜氧化损伤的实验研究[J].同济医科大学学报,1999,28(4)：332-334.
[105]固本财,马建林,田元,等.高胆固醇饲料诱导红细胞膜脂蛋白、脂质过氧化和膜流动性的改变[J].微循环学杂志,1996,6(3)：41-42.
[106]Amos W B, White J G.How the confocal laser scanning microscope entered biological research[J].Biology of the Cell,2003,95:335-342.
[107]赵启韬,苗俊英.激光共聚焦显微镜在生物医学研究中的应用[J].北京生物医学工程,2003,22(1)：52-54.
[108]Rachita M, Sushil P, Uday K.Confocal laser microscope [J].Indian J Dermatol Venereol Leprol,2006,72(5):394-397.
[109]Diaspro A, Annunziata S, RaimondoM, et al.Asingle-pinhole confocal laser scanning microscope for 3-D imaging of biostructures [J]. IEEE Eng Med Biol.,1999, 18:106-110.
[110]Zimprich F, Ashworth R, Bolsover S.Real-time measurements of calcium dynamics in neurons developing in situ within zebrafish embryos[J].Pflugers Arch, 1998,36:489-493.
[111]宋怀宇,赵启韬,王万忠.激光共聚焦显微镜对肝组织纤维化程度的荧光定量分析[J].中华消化杂志,2003,23(7)：437-438.
[112]Schuurhuis DH, Ioan-Facsinay A, Nagelkerken B, et al.Anti-genantibody immune complexes empower dendritic cells to effi-ciently prime specific CD8+CTLresponses in vivo[J].J Immunol,200,168(5):2240-2242.
[113]Iwasaki A, Kelsall BL.Localization of distinct Peyer's patch dendritic cell subsets and their recruitment by chemokines macrophage inflammatory protein(MIP)-3alpha,,MIP-3beta and secondary lymphoid organ chemokine[J].J Exp Med,2000,191(8):1381-1382.
[114]张赞,程光,韩卫宁,等.超抗原对NK细胞CD226分子表达与功能的调节[J].细胞与分子免疫学杂志,2006,22(1)：4-5.
[115]刘峰,姚咏明,徐姗,等.高迁移率族蛋白B1对小鼠巨噬细胞免疫功能影响的受体机制[J].中华实验外科杂志,2007,24(2)：166.
[116]谭玉珍,王海杰,张文彩,等.免疫球蛋白超家族黏附分子在淋巴管和不同血管内皮细胞的表达[J].解剖学报,2006,37(1)：52-53.
[117]张赞,程光,韩卫宁,等.超抗原对NK细胞亚群凋亡诱导配体表达与功能的调节[J].免疫学杂志,2006,22(3)：239-240.
[118]朱昌来,林琳,张天一.肿瘤源性热休克蛋白gp96诱导淋巴细胞反应及其抗肿瘤效应[J].中国免疫学杂志,2007,23(3)：234-235.
[119]张姿,刘佳佳,姚富丽,等.ONO-AE-248诱导的中性粒细胞非凋亡性程序化细胞死亡的形态学变化[J].细胞与分子免疫学杂志,2007,23(5)：413.
[120]张馨予,李晓眠,杨洁.医学免疫学研究中激光共聚焦显微镜的应用.天津医科大学学报,2008,14(2)：267-273.
[121]Hamrah P, Zhang Q, Liu Y, et a 1. Novel characterization of MHC class II-negative population of resident corneal Langerhans celltype dendritic cells[J].Invest Ophthalmol Vis Sci,2002,43(3):639-640.
[122]Stoll S, Delon J, BrotzTM, et al. Dynamic imagingofTcell-dendritic cell interaction in lymph nodes[J].Science,2002,296(5574):1873-1874.
© 2004-2018 中国地质图书馆版权所有 京ICP备05064691号 京公网安备11010802017129号 地址：北京市海淀区学院路29号 邮编：100083 电话：办公室：(+86 10)66554848；文献借阅、咨询服务、科技查新：66554700 |